10X GENOMICS INC10X GENOMICS INC10X GENOMICS INC

10X GENOMICS INC

No trades
See on Supercharts
Market capitalization
‪57.05 B‬MXN
−36.97MXN
‪−4.33 B‬MXN
‪10.51 B‬MXN
‪98.51 M‬
Beta (1Y)
2.98

About 10X GENOMICS INC

CEO
Serge Saxonov
Headquarters
Pleasanton
Employees (FY)
‪1.26 K‬
Founded
2012
FIGI
BBG00Z6QRNX2
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of TXG is 763.78 MXN — it has increased by 4.24% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange 10X GENOMICS INC stocks are traded under the ticker TXG.
10X GENOMICS INC is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.
TXG stock is 4.07% volatile and has beta coefficient of 2.98. Check out the list of the most volatile stocks — is 10X GENOMICS INC there?
TXG earnings for the last quarter are −13.77 MXN per share, whereas the estimation was −8.03 MXN resulting in a −71.58% surprise. The estimated earnings for the next quarter are −5.93 MXN per share. See more details about 10X GENOMICS INC earnings.
10X GENOMICS INC revenue for the last quarter amounts to ‪2.68 B‬ MXN despite the estimated figure of ‪2.64 B‬ MXN. In the next quarter revenue is expected to reach ‪3.10 B‬ MXN.
Yes, you can track 10X GENOMICS INC financials in yearly and quarterly reports right on TradingView.
TXG net income for the last quarter is ‪−831.46 M‬ MXN, while the quarter before that showed ‪−1.62 B‬ MXN of net income which accounts for 48.70% change. Track more 10X GENOMICS INC financial stats to get the full picture.
Today 10X GENOMICS INC has the market capitalization of ‪56.03 B‬, it has decreased by 8.35% over the last week.
No, TXG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TXG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 10X GENOMICS INC stock right from TradingView charts — choose your broker and connect to your account.
TXG reached its all-time high on Apr 29, 2021 with the price of 3938.72 MXN, and its all-time low was 575.00 MXN and was reached on Oct 31, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has ‪1.26 K‬ employees. See our rating of the largest employees — is 10X GENOMICS INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 10X GENOMICS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 10X GENOMICS INC stock shows the sell signal. See more of 10X GENOMICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on 10X GENOMICS INC future price: according to them, TXG price has a max estimate of 1111.30 MXN and a min estimate of 512.91 MXN. Read a more detailed 10X GENOMICS INC forecast: see what analysts think of 10X GENOMICS INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 10X GENOMICS INC EBITDA is ‪−2.73 B‬ MXN, and current EBITDA margin is −25.58%. See more stats in 10X GENOMICS INC financial statements.